On Monday, Evolus Inc (NASDAQ: EOLS) was -4.21% drop from the session before settling in for the closing price of $10.69. A 52-week range for EOLS has been $9.25 – $17.82.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 51.00% over the last five years. When this article was written, the company’s average yearly earnings per share was at 40.20%. With a float of $56.11 million, this company’s outstanding shares have now reached $63.50 million.
The firm has a total of 332 workers. Let’s measure their productivity. In terms of profitability, gross margin is 67.4%, operating margin of -11.73%, and the pretax margin is -18.69%.
Evolus Inc (EOLS) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Evolus Inc stocks. The insider ownership of Evolus Inc is 11.76%, while institutional ownership is 81.97%. The most recent insider transaction that took place on Mar 27 ’25, was worth 77,512. In this transaction an insider of this company sold 6,251 shares at a rate of $12.40, taking the stock ownership to the 508,619 shares. Before that another transaction happened on Mar 18 ’25, when Company’s insider sold 27,904 for $13.26, making the entire transaction worth $369,868. This insider now owns 362,467 shares in total.
Evolus Inc (EOLS) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 40.20% per share during the next fiscal year.
Evolus Inc (NASDAQ: EOLS) Trading Performance Indicators
You can see what Evolus Inc (EOLS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.21. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.81, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach 0.66 in one year’s time.
Technical Analysis of Evolus Inc (EOLS)
Analysing the last 5-days average volume posted by the [Evolus Inc, EOLS], we can find that recorded value of 1.07 million was better than the volume posted last year of 0.82 million. As of the previous 9 days, the stock’s Stochastic %D was 19.08%. Additionally, its Average True Range was 0.76.
During the past 100 days, Evolus Inc’s (EOLS) raw stochastic average was set at 12.58%, which indicates a significant decrease from 13.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.91% in the past 14 days, which was lower than the 63.20% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.41, while its 200-day Moving Average is $13.55. Now, the first resistance to watch is $10.76. This is followed by the second major resistance level at $11.27. The third major resistance level sits at $11.81. If the price goes on to break the first support level at $9.71, it is likely to go to the next support level at $9.17. Should the price break the second support level, the third support level stands at $8.66.
Evolus Inc (NASDAQ: EOLS) Key Stats
There are 63,587K outstanding shares of the company, which has a market capitalization of 651.13 million. As of now, sales total 266,270 K while income totals -50,420 K. Its latest quarter income was 78,950 K while its last quarter net income were -6,790 K.
